{"date": "2022-02-11 01:01:12.638000+00:00", "ticker": "AMZN", "mrkt_info": {"open": 3223.79, "close": 3065.87}, "html": "<div class=\"storyContent\" lang=\"en\"><style type=\"text/css\">.storyContent * {border-color:inherit !important;outline-color:inherit !important;}</style><span>\n              <p>NEW YORK, Feb 11 (IFR) - Today\u2019s red-hot inflation reading provided another setback to hopes for a near-term rebound in US ECM.</p>\n              <p>Just when it looked as if investors might be returning to their default bullishness and IPO launch discussions seemed to be getting serious again, the DJIA tumbled 526.47 points (-1.47%) as investors digested CPI data showing a 0.6% increase in consumer prices in January.</p>\n              <p>It was the seventh time in the past 10 months the reading had risen more than 0.5%, while the year-on-year increase of 7.5% was the highest in 40 years.</p>\n              <p>Challenging the optimistic theory that Fed officials are more dovish than the bond market, St Louis Fed president James Bullard chimed in that the data had made him dramatically more hawkish and he wanted to see a full percentage point Fed funds rate rise by July 1.</p>\n              <p>Futures markets are now pricing in a nearly 90% chance of a 50bp rate rise (up from 24% yesterday) at the next FOMC meeting on March 15-16.</p>\n              <p>That is almost five weeks away, an eternity for US ECM bankers eager to get some Q1 fees under their belt.</p>\n              <p>One senior ECM banker said he was still confident that Q1 would bring some IPOs but conceded issuance would be \u201cnews flow and data-dependent\u201d.</p>\n              <p>The next Fed meeting could be \u201ca little bit of a bogeyman\u201d for capital markets, another ECM banker said.</p>\n              <p>\u201cNot that you want to be too scared of it but it\u2019s an event that\u2019s going to be closely followed to see what the outlook for rates is,\u201d the second banker said.</p>\n              <p>Already the buyside was showing \u201cno fear of missing out on IPOs like last year\u201d.</p>\n              <p>The more guarded tone is also reflected in the earnings season as companies seek to emphasize their cashflow generation.</p>\n              <p>An unlikely example this week was <b>Uber Technologies</b>, whose Q4 results late yesterday saw a substantial improvement at the adjusted Ebitda line and included a guide towards greater profitability this year (thought the stock still fell 6.1% today).</p>\n              <p>\u201cYou are seeing the symptoms of higher rates. People are still focused on top-line growth but are highlighting operating leverage, cashflow and profitability a little bit more,\u201d the second banker said.</p>\n              <p>Unfortunately, the earnings season brought more disappointment today from the struggling 2021 IPO class.</p>\n              <p>Shares of Max Levchin\u2019s <b>Affirm</b> slumped 21.4% after the \u201cbuy now, pay later\u201d firm dropped its fiscal Q2 results early via Twitter and its full-year revenue outlook came up short.</p>\n              <p>One of last year\u2019s best performing IPOs out of the gate (the stock nearly doubled on debut in January 2022), Affirm closed today\u2019s session at $58.68, still above its $49.00 price but down precipitously from $176.65 in November.</p>\n              <p>In the absence of IPOs and (very little) follow-on activity, and benefiting from market volatility, the most interesting deal flow this week is coming from the CB market.</p>\n              <p>Having already availed itself of the full suite of capital market product during the pandemic, serial issuer <b>Norwegian Cruise Line</b> (Wall Street\u2019s new favorite customer?) embarked on a $435m exchangeable bond today as part of broader financing (more below).</p>\n              <p>Cruise lines (more so than airlines) remain a live prospect for ECM deals as they continue to work on shoring up their liquidity and addressing their debt-laden balance sheets post-Covid.</p>\n              <p>But if 2021 was the year for everyone to sell stock at a high (inflated?) price, then 2022 might be a time to buy it back at (substantially) lower prices.</p>\n              <p>Less than a year after it raised $1.25bn from a zero-coupon CB that allows holders to convert at share prices above $130.03, micro-blogger <b>Twitter</b> today revealed a $4bn buyback, including a $2bn accelerated share repurchase.</p>\n              <p>Twitter shares closed at $37.08, making the sell-high, buy-low turnabout an astute bit of corporate finance (though it will still owe the money back but not until 2026).</p>\n              <p>Of course, there were many examples last year of tech companies opportunistically raising equity capital at very attractive terms (that is, because they could rather than having a specific use of proceeds).</p>\n              <p>Still, buying back stock, along with M&amp;A, could be crucial to putting a floor under sector valuations.</p>\n              <p>Even <b>Amazon</b> is buying back stock for the first time since 2012, <a href=\"https://www.marketwatch.com/story/amazon-repurchased-stock-in-january-for-the-first-time-in-a-decade-2022-02-04\">revealing</a> last week it repurchased $1.3bn of stock in January.</p>\n              <h3>Back to port...again</h3>\n              <p>Still charting a course out of the stormy seas it has had to navigate for nearly two years, <b>Norwegian Cruise Line </b>dipped into the market today with a three-part $2bn combo equity-linked and bond financing to take out remaining high-cost funding the cruise ship operator took on at the height of Covid-19 in 2020.</p>\n              <p>Norwegian remains saddled with $11.9bn of long-term debt, so realistically this refinancing is like chipping ice off an iceberg.</p>\n              <p>In any case, <span>JP Morgan</span>, <span>Goldman Sachs</span> and <span>Mizuho Securities</span> acted as joint books on the three-pronged sale of a $435m five-year convertible, $1bn of five-year secured notes, and $600m of seven-year unsecured notes.</p>\n              <p>Norwegian also revealed it expects to report $1.6bn\u2013$1.8bn of adjusted Ebitda losses on revenue of just $600m\u2013$800m for 2021. Liquidity stood at $2.7bn at the end of the year, down from $3.3bn at the end of 2020.</p>\n              <p>It is using the proceeds to take out the remaining $962.5m of 10.25% and 12.25% debt outstanding to reduce interest expense but paying a premium to do so.</p>\n              <p>The new 2027 and 2029 debt is being sold at 6.25%\u20136.5% and 8%\u20138.25% annual coupons, implying a roughly $40m saving in annual interest expenses.</p>\n              <p>Norwegian\u2019s latest venture into capital markets is also about staunching the heavy dilution shareholders have suffered as the company repeatedly sold stock to weather the pandemic \u2013 through multiple equity offerings, Norwegian has nearly doubled shares outstanding to 416.9m since the pandemic began.</p>\n              <p>Here it is paying a higher coupon on the CB (2.5%-3%) in return for a higher conversion premium (47.5%\u201352.5%). The new CB can also be settled entirely in cash, or a combination of stock and cash, enabling the company to manage the amount of stock issued upon conversion.</p>\n              <p>\u201cWe have seen a lot of interest from fundamental investors seeking to add exposure to the name,\u201d said one equity-linked banker. \u201cI suspect the CB prices at the tight-end of price talk.\u201d</p>\n              <p>Norwegian shares fell 4.6% to $22.63 today, implying a conversion price on the new CB of about $34.00.</p>\n              <p>This refinancing is similar to the one undertaken in November that saw the cruise ship operator raise $2.25bn from the concurrent sale of 46.9m shares at $23.64 and a 1.125% CB maturing in February 2027 at share prices above $33.69, a 42.5% premium.</p>\n              <p>This time around, Norwegian is having to pay a make-whole premium to take out the 10.25s and 12.25s, costing it about 120% of par. In November, it was able to exercise equity claw-back provisions to take them out at 110.25% and 112.25%, respectively.</p>\n              <p>This is all about positioning the slow-moving Norwegian if and/or when earnings begin to flow, which could happen this year assuming the worst of Covid really is behind the battered cruise industry.</p>\n              <h3>Buzzed</h3>\n              <p>Faced with dwindling cash and ongoing need for money, <b>Vera Therapeutics</b> last night raised the $75m it was looking for but only by offering investors a massive concession.</p>\n              <p>After two days of marketing, <span>JP Morgan</span>, <span>Cowen</span> and <span>Evercore</span> priced 5m Vera shares at $15.00, a gaping 21.3% discount to the $19.05 last sale and a 26.4% file-to-offer discount. The offering was upsized by 20% from 4m at launch.</p>\n              <p>Vera shares closed today\u2019s session at $17.80, delivering a positive mark for investors that participated.</p>\n              <p>The same tight group of investors that supported Vera to date, including via its $48m IPO priced at $11.00 in May last year, likely underpinned demand for the offering.</p>\n              <p>Vera, as we pointed out in Tuesday\u2019s briefing, is barely public with just 10 institutions owning more than 80% of the biotech. The stock barely trades at all. Just 900,000 shares changed hands today.</p>\n              <p>Vera plans to spend $75m on drug development this year, including $60m for a Phase III trial on a lupus drug and the other $15m on a Phase II trial on a drug it recently acquired from Pfizer.</p>\n              <p>The biotech had just $79.7m of cash at December 31.</p>\n              <p>Vera believes the $155m of cash it will carry post-offering is enough to keep it going through the middle of 2024.</p>\n              <h3>Piping down</h3>\n              <p>Like most other investment banks, <b>Piper Sandler</b> ended a record 2021 for ECM with a Q4 slowdown in activity that has spilled into early 2022.</p>\n              <p>Reporting its latest results today, Piper said its Q4 corporate financing revenues (largely ECM) fell 25% versus the same quarter in 2020 (and 18% versus Q3).</p>\n              <p>The firm participated in 45 equity transactions, down 10% versus the linked quarter, though book-run equity transactions rose 14% to 33.</p>\n              <p>This reflected solid contributions from the healthcare, financial services, consumer and technology sectors, the firm said.</p>\n              <p>Though some firms have not openly conceded as much yet, Piper CEO Chad Abraham told analysts he expected equity issuance to decline \u201csubstantially\u201d this year from the record levels of the past two years.</p>\n              <p>Abraham said the first five to six weeks of 2022 had been \u201cincredibly slow\u201d in ECM, though this was not the first time this had happened in the past four or five years and rarely did it last for a whole quarter.</p>\n              <p>Asked if clients were simply delaying their IPOs or canceling them altogether, Abraham said: \u201cI would say what happens is you have to get a few clients (on the IPO side) to sort of be first and test the market and get some good results.</p>\n              <p>\u201cThey want to do the transaction and you just need less volatility. And it takes a few weeks after the market stabilizes and then you start to see clients go.\u201d</p>\n              <p>Though some banks expect follow-on activity to return more quickly than IPOs, Abraham said healthcare/biotech issuance could take \u201ca little bit longer\u201d because it depended on share prices.</p>\n              <p>Even with the Q4 moderation, Piper reported record corporate finance revenues of $362.8m in 2021, up 23% from a robust 2020.</p>\n              <p>For the year, the firm completed 214 equity transactions, 141 of which were bookrun.</p>\n              <p>Abraham noted the US equity issuance fee pool surpassed $20bn for the first time last year, more than double the 10-year average, while the fee pool for sub-$5bn market cap companies in healthcare alone was $3.6bn, nearly double the decade average.</p>\n              <p>\u201cInnovation, investor demand and significant capital requirements have led healthcare companies to raise record amounts of money,\u201d he said.</p>\n              <p>\u201cWe believe there is a structural change in the size of the healthcare financing market that will support higher levels of activity relative to historical averages.\u201d</p>\n              <h3>Links</h3>\n              <p>Crypto exchange <a href=\"https://www.forbes.com/sites/forbespr/2022/02/10/forbes-announces-200-million-strategic-investment-from-binance/?sh=1888a29357e2\"><b>Binance</b></a> invests $200m in <b>Forbes</b> via SPAC PIPE funding.</p>\n              <p>\n                <a href=\"https://www.reuters.com/business/finance/credit-suisse-posts-2-billion-swiss-franc-q4-loss-2022-02-10/\">\n                  <b>Credit Suisse</b>\n                </a> flags weak 2022, ends torrid year with $2.2bn quarterly loss.</p>\n              <p>\n                <a href=\"https://s22.q4cdn.com/826641620/files/doc_financials/2021/q4/Final-Q4'21-Shareholder-letter.pdf\">\n                  <b>Twitter</b>\n                </a> to buy back $4bn of stock, including $2bn via an ASR.</p>\n              <p>\n                <a href=\"https://www.informa.com/globalassets/documents/investor-relations/2022/informa-plc---divestment-of-pharma-intelligence-for-1.9bn.pdf\">\n                  <b>Warburg Pincus</b>\n                </a> acquires <b>Informa</b>\u2019s pharma intelligence unit for $2.6bn.</p>\n              <p>\n                <a href=\"https://investor.zendesk.com/ir-home/press-releases/press-releases-details/2022/Zendesk-Board-Rejects-Unsolicited-Non-Binding-Acquisition-Proposal-From-Consortium-of-Private-Equity-Firms/default.aspx\">\n                  <b>Zendesk</b>\n                </a> rejects unsolicited private equity offers at $127-$132 per share.</p>\n              <p>\n                <a href=\"https://www.cnbc.com/2022/02/10/zillow-z-earnings-q4-2021-.html\">\n                  <b>Zillow</b>\n                </a> soars on upbeat outlook, faster-than-expected run-off of home-flipping operation.</p>\n              <h3>Priced</h3>\n              <p>\n                <b>Monday</b>\n              </p>\n              <p>\n                <a href=\"https://www.sec.gov/edgar/browse/?CIK=1883788\">\n                  <b>Aurora Technology Acquisition</b>\n                </a>\n                <b> (Singapore, SPAC)</b> \u2013 $200m IPO. 20m units (100% prim) at $10.00. Each unit comprises one share, one warrant and one-tenth right<span>. MAXM</span>. <span>Nasdaq \u201cATAKU\u201d. Zachary Wang, Cathryn Chen, Yida Gao. Tech (Asian-American entrepreneurs). 12 months. 100% in trust. Priced pre-open Monday.</span></p>\n              <p>\n                <a href=\"https://www.sec.gov/edgar/browse/?CIK=711669&amp;owner=exclude\">\n                  <b>Colony Bankcorp</b>\n                </a>\n                <b> (US, bank) </b>\u2013 $55m FO. 3.35m shares (100% prim) at $16.50 versus $17.02 last sale. <span>HOVD, JSM</span>.</p>\n              <p>\n                <a href=\"http://eqbank.investorroom.com/2022-02-07-Equitable-Announces-Agreement-to-Acquire-Concentra-Bank-and-Concurrent-200-Million-Bought-Deal-Offering-of-Subscription-Receipts\">\n                  <b>Equitable Bank</b>\n                </a>\n                <b> (Canada, banking)</b> \u2013 C$200m ($158m) Bought deal. 2.84m subscription receipts (100% prim) at C$70.50 versus C$73.40 last sale. <span>TD, RBC. Buying Concentra Bank for C$470m ($370m).</span></p>\n              <p>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001875257&amp;owner=include&amp;count=40\">\n                  <b>LIV Capital Acquisition II</b>\n                </a>\n                <b> (Mexico, SPAC)</b> \u2013 $100m IPO. 10m units (100% prim) at $10.00. Each unit comprises one share and three-quarters warrant. <span>EBC. LIV Capital. Mexico. 15 months. 102% in trust</span>.</p>\n              <p>\n                <b>Tuesday</b>\n              </p>\n              <p>\n                <a href=\"https://nam12.safelinks.protection.outlook.com/?url=http:%2F%2Fifr-track.refinitiv.com%2Ff%2Fa%2FQko9HbKLhf_7i8LkUjBW7A~~%2FAAABiwA~%2FRgRiCapcP0RgaHR0cHM6Ly93d3cuc2VjLmdvdi9jZ2ktYmluL2Jyb3dzZS1lZGdhcj9hY3Rpb249Z2V0Y29tcGFueSZDSUs9MDAwMTgwMTQxNyZvd25lcj1pbmNsdWRlJmNvdW50PTQwVwVzcGNldUIKYCJhJSdgvWciNFIbc3RlcGhlbi5sYWNleUByZWZpbml0aXYuY29tWAQAAAAA&amp;data=04%7C01%7Cstephen.lacey%40refinitiv.com%7C64c7ee00f660475a737608d8cfbb2d45%7C71ad2f6261e244fc9e8586c2827f6de9%7C0%7C0%7C637487750148201453%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=DawMZV%2FpzLffwaYNj9aFySuYq7t2BLilKQHA2%2Fw%2BL3k%3D&amp;reserved=0\">\n                  <b>byNordic Acquisition</b>\n                </a>\n                <b> (Sweden, SPAC)</b> \u2013 $150m SPAC IPO. 15m units at $10.00. Each unit comprises one share and one-half warrant. <span>KBW, DREX, IBNK. Nasdaq \u201cBYNOU\u201d. Jonas Olsson. Tech, Europe. 15 months. 102% in trust.</span></p>\n              <p>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001873964&amp;owner=include&amp;count=40\">\n                  <b>Counter Press Acquisitio</b>\n                </a>\n                <b>\n                  <u>n</u>\n                </b>\n                <b> (US, SPAC)</b> \u2013 $75m IPO. 7.5m units (100% prim) at $10.00. Each unit comprises one share and one-half warrant. <span>BTIG, EBC. Nasdaq \u201cCPAQU\u201d. Paul Conway, Michael Kalt. Sports media. 12 months. 101.5% in trust.</span></p>\n              <p>\n                <a href=\"https://ri.equatorialenergia.com.br/en/\">\n                  <b>Equatorial Energia</b>\n                </a>\n                <b> (Brazil, utility)</b> \u2013 R$2.8bn ($530m) FO. 118.4m shares (100% prim) at R$23.50 versus R$23.76 last sale and R$$22.65 at launch. <span>CS, CITI, UBS, XP, GS. Upsized from 87.7m shares with 35% hot issue provision.</span></p>\n              <p>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001900402&amp;owner=include&amp;count=40\">\n                  <b>Evergreen</b>\n                </a>\n                <b> (Malaysia, SPAC)</b> \u2013 $100m IPO. 10m units (100% prim) at $10.00. Each unit comprises one share and one warrant. <span>EFH. Nasdaq \u201cEVGRU\u201d. Liew Choon Lian. Tech. 12 months. 101.5% in trust.</span></p>\n              <p>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?CIK=0001564408&amp;owner=exclude\">\n                  <b>Snap</b>\n                </a>\n                <b> (US, social media) </b>\u2013 $1.3bn 6y cvt priced at 0.125%, up 50% versus 0.125%-0.625% and 45%-50% marketing.<span> JPM, MS, GS. Upsized from $1.25bn. Capped call to $93.90, a 150% premium.</span></p>\n              <p>\n                <b>Wednesday</b>\n              </p>\n              <p>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001831828&amp;owner=include&amp;count=40\">\n                  <b>Vera Therapeutics</b>\n                </a>\n                <b> (US, biotech)</b> \u2013 $75m FO. 4.99m shares (100% prim) at $15.00 versus $19.05 last sale and $20.37 at launch. <span>JPM, COWN, EVER. Went public in May 2021 at $11.00 a share. Upsized from 4m shares.</span></p>\n              <p>\n                <b>Thursday</b>\n              </p>\n              <p>\n                <a href=\"https://nam12.safelinks.protection.outlook.com/?url=http:%2F%2Fifr-track.refinitiv.com%2Ff%2Fa%2FqFvMS-10RRrvBqOTouJWQA~~%2FAAABiwA~%2FRgRiCapcP0RgaHR0cHM6Ly93d3cuc2VjLmdvdi9jZ2ktYmluL2Jyb3dzZS1lZGdhcj9hY3Rpb249Z2V0Y29tcGFueSZDSUs9MDAwMTg0MjU1NiZvd25lcj1pbmNsdWRlJmNvdW50PTQwVwVzcGNldUIKYCJhJSdgvWciNFIbc3RlcGhlbi5sYWNleUByZWZpbml0aXYuY29tWAQAAAAA&amp;data=04%7C01%7Cstephen.lacey%40refinitiv.com%7C64c7ee00f660475a737608d8cfbb2d45%7C71ad2f6261e244fc9e8586c2827f6de9%7C0%7C0%7C637487750148320925%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=OgtZvSTMKz7WECB%2FpggVafpUf4gQxSYRkhQnjJVN0%2Fw%3D&amp;reserved=0\">\n                  <b>HNR Acquisition</b>\n                </a>\n                <b> (US, SPAC)</b> \u2013 $75m IPO. 7.5m units (100% prim) at $10.00. Each unit comprises one share and three-fourths of a warrant. <span>EFH. NYSE American \u201cHNRAU\u201d. Houston Natural Resources. E&amp;P. 12 months. 102% in trust.</span></p>\n              <p>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001857518&amp;owner=include&amp;count=40\">\n                  <b>Jaguar Global Growth Corporation I</b>\n                </a>\n                <b> (US, SPAC)</b> \u2013 $200m IPO. 20m units (100% prim) at $10.00. Each unit comprises one share and one-half warrant. <span>CITI, BARC. Nasdaq \u201cJGGCU\u201d. Jaguar Growth Partners. Proptech. 18 months. 102% in trust</span>.</p>\n              <h3>Withdrawn</h3>\n              <p>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001849030&amp;owner=include&amp;count=40\">\n                  <b>Crucible Acquisition II</b>\n                </a>\n                <b> (US, SPAC)</b> \u2013 $200m IPO. <span>CS. Foundry Group (James Lejeal, Brad Feld). Software.</span></p>\n              <p>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001849035&amp;owner=include&amp;count=40\">\n                  <b>Crucible Acquisition III</b>\n                </a>\n                <b> (US, SPAC)</b> \u2013 $350m IPO. <span>CS. Foundry Group (James Lejeal, Brad Feld). Software.</span></p>\n              <p>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001846064&amp;owner=include&amp;count=40\">\n                  <b>High Cape Capital Acquisition II</b>\n                </a>\n                <b> (US, SPAC) </b>\u2013 $200m IPO. <span>CANT. HighCape. Kevin Rakin. Life sciences. </span></p>\n              <h3>Calendar</h3>\n              <p>\n                <b>February 10: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001862733&amp;owner=include&amp;count=40\">\n                  <b>Cariloha</b>\n                </a>\n                <b> (US, retailer) </b>\u2013 $32.2m IPO. 2.3m shares (100% prim) at $12-$14. <span>ROTH, OPCO. Nasdaq Select \u201cALOHA\u201d.</span></p>\n              <p>\n                <b>February 10: </b>\n                <a href=\"https://www.sec.gov/edgar/browse/?CIK=1513761&amp;owner=exclude\">\n                  <b>Norwegian Cruise Line</b>\n                </a>\n                <b> (US, cruise ships)</b> \u2013 $435m 5y exch being marketed at 2.5%-3%, up 47.5%-52.5%. <span>JPM, GS, MIZU</span>.<span> Concurrent $1bn secured notes due 2027 and $600m unsecured notes due 2029</span>.</p>\n              <p>\n                <b>February 10: </b>\n                <a href=\"https://www.sec.gov/edgar/browse/?CIK=1581280&amp;owner=exclude\">\n                  <b>Twist Bioscience</b>\n                </a>\n                <b> (US, biotech)</b> \u2013 $200m FO. Fixed size (100% prim) versus $64.61 at launch. <span>JPM, GS, COWN, WBLR</span>.</p>\n              <p>\n                <b>February 17: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001875224&amp;owner=include&amp;count=40\">\n                  <b>Altmore BDC</b>\n                </a>\n                <b> (US, BDC)</b> \u2013 $103.3m IPO. 6.67m shares (100% prim) at $14.50-$15.50. <span>LDNT, COMP, OPCO. Nasdaq \u201cABDC\u201d.</span></p>\n              <h3>Registered IPO backlog</h3>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001689258&amp;owner=include&amp;count=40\">\n                  <b>5.11 ABR</b>\n                </a>\n                <b> (US, outdoor apparel)</b> \u2013 $100m IPO. Terms TBD (100% prim). <span>MS, JEFF, RWB. WBLR, RJ. Nasdaq \u201cVXI\u201d. DSP. Portfolio company of Compass Diversified.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001792694&amp;owner=include&amp;count=40\">\n                  <b>Affinia Therapeutics</b>\n                </a>\n                <b> (US, biotech)</b> \u2013 $100m IPO. Terms TBD (100% prim). <span>GS, JEFF, PS, CHDN. Nasdaq \u201cAFTX\u201d</span>.</p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001601563&amp;owner=include&amp;count=40\">\n                  <b>Agendia</b>\n                </a>\n                <b> (Netherlands, diagnostics)</b> \u2013 $75m IPO. Terms TBD (100% prim). <span>GS, CITI, COWN, STFL. Nasdaq \u201cAGDX\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/Archives/edgar/data/1836056/000119312521177104/0001193125-21-177104-index.htm\">\n                  <b>Ambrx Biopharma</b>\n                </a>\n                <b> (Cayman Islands/US, biotech)</b> \u2013 $100m IPO. Terms TBD (100% prim). <span>GS, BOFA, COWN. NYSE \u201cAMAM\u201d ADS offering.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001353538&amp;owner=include&amp;count=40\">\n                  <b>Appgate</b>\n                </a>\n                <b> (US, security software)</b> \u2013 $75m IPO. Terms TBD (100% prim). <span>JEFF, GUGG. Trades OTC \u201cAPGT\u201d</span>.</p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001144879&amp;owner=include&amp;count=40\">\n                  <b>Applied Blockchain</b>\n                </a>\n                <b> (US, crypto mining) </b>\u2013 $75m IPO. Terms TBD (100% prim). <span>BRLY. Nasdaq \u201cAPLD\u201d. Trades Nasdaq OTC \u201cAPLD\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001817241&amp;owner=include&amp;count=40\">\n                  <b>Artiva Biotherapeutics</b>\n                </a>\n                <b> (US, biotech) </b>\u2013 $100m IPO. Terms TBD (100% prim).<span> GS, COWN, EVER, CGEN. Nasdaq \u201cRTVA\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/edgar/browse/?CIK=1330016&amp;owner=exclude\">\n                  <b>Basis Global Technologies</b>\n                </a>\n                <b> (US, adtech)</b> \u2013 $100m IPO. Terms TBD (100% prim). <span>GS, BOFA, RBC, BMO, STFL. Nasdaq \u201cBASI\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001860742&amp;owner=include&amp;count=40\">\n                  <b>Bausch &amp; Lomb</b>\n                </a>\n                <b> (US, eye health) </b>\u2013 $2.5bn-$3bn IPO. Terms TBD (100% sec). <span>MS, GS, CITI, JPM, BARC, BOFA, GUGG. NYSE/TSX \u201cBLCO\u201d. Spin-off from Bausch Health.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001865782&amp;owner=include&amp;count=40\">\n                  <b>BrightSpring Health Services</b>\n                </a>\n                <b> (US, healthcare) </b>\u2013 $500m IPO. Terms TBD (100% prim). <span>GS, JEFF, KRR, CS, GUGG, SVBL. Nasdaq \u201c\u201d. Concurrent mandatory convertible offering. Portfolio company of KKR, Walgreens Boots Alliance.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001756702&amp;owner=include&amp;count=40\">\n                  <b>Castle Creek Biosciences</b>\n                </a>\n                <b> (US, biotech) </b>\u2013 $100m IPO. Terms TBD (100% prim). <span>CITI, PS, BARC. Nasdaq \u201cCCBS\u201d</span>.</p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?company=chobani&amp;match=&amp;filenum=&amp;State=&amp;Country=&amp;SIC=&amp;myowner=exclude&amp;action=getcompany\">\n                  <b>Chobani</b>\n                </a>\n                <b> (US, yogurt)</b> \u2013 $100m IPO. Terms TBD (100% prim). <span>GS, BOFA. Nasdaq \u201cCHO\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001879751&amp;owner=include&amp;count=40\">\n                  <b>Coforge</b>\n                </a>\n                <b> (India, IT services) </b>\u2013 $1bn NYSE IPO. Terms TBD (100% sec).<span> CITI, JPM, BARC, BOFA, EVER. Trades on National Stock Exchange of India, Bombay Stock Exchange \u201cCOFORGE\u201d. NYSE \u201c\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001882148&amp;owner=include&amp;count=40\">\n                  <b>Desri</b>\n                </a>\n                <b> (US, renewable energy)</b> \u2013 $100m IPO. Terms TBD (prim, sec). <span>GS, BOFA. Nasdaq \u201cDESR\u201d. Portfolio company of D.E. Shaw.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001879560&amp;owner=include&amp;count=40\">\n                  <b>Dynasty Financial Partners</b>\n                </a>\n                <b> (US, asset mgmt)</b> \u2013 $100m IPO. Terms TBD (100% sec). <span>GS, JPM, CITI, RBC</span>. <span>DSP</span>.</p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001861853&amp;owner=include&amp;count=40\">\n                  <b>Everside Health</b>\n                </a>\n                <b> (US, primary healthcare provider) </b>\u2013 $500m IPO. Terms TBD (100% prim). <span>MS, JPM, GS, BOFA, WBLR. NYSE \u201cEVSD\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001888447&amp;owner=include&amp;count=40\">\n                  <b>Excelerate Energy</b>\n                </a>\n                <b> (US, liquified natural gas) </b>\u2013 $250m IPO. Terms TBD (100% prim). <span>BARC, JPM, MS. NYSE \u201cEE\u201d. 5% DSP.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001883631&amp;owner=include&amp;count=40\">\n                  <b>Fogo Hospitality</b>\n                </a>\n                <b> (US, restaurants)</b> \u2013 $100m IPO. Terms TBD (prim, sec). <span>MS, BOFA, JEFF. NYSE \u201cFOGO\u201d. Owns Fogo de Chao restaurant chain.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001785343&amp;owner=include&amp;count=40\">\n                  <b>Freehold Properties</b>\n                </a>\n                <b> (US, cannabis REIT) </b>\u2013 $115m IPO. Terms TBD (100% prim). <span>STFL, COWN. Nasdaq \u201cFHP\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001661123&amp;owner=include&amp;count=40\">\n                  <b>Gerson Lehrman</b>\n                </a>\n                <b> (US, expert networks) </b>\u2013 $100m IPO. Terms TBD (100% prim). <span>MS, GS, BOFA, BARC, JEFF, BAIRD, WBLR. Nasdaq \u201cGLGX\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001867684&amp;owner=include&amp;count=40\">\n                  <b>HomeSmart</b>\n                </a>\n                <b> (US, real estate brokerage) </b>\u2013 $100m IPO. Terms TBD (prim/sec). <span>JPM, BOFA, STFL, OPP. Nasdaq \u201cHS\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001752797&amp;owner=include&amp;count=40\">\n                  <b>iCIMS</b>\n                </a>\n                <b> (US, cloud software) </b>\u2013 $100m IPO. Terms TBD (100% prim). <span>MS, JPM, CITI. Nasdaq \u201cTLNT\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001484074&amp;owner=include&amp;count=40\">\n                  <b>Intuity Medical</b>\n                </a>\n                <b> (US, diagnostics) </b>\u2013 $75m IPO. Terms TBD (100% prim). <span>GS, JEFF, PS. Nasdaq \u201cPOGO\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001866907&amp;owner=include&amp;count=40\">\n                  <b>Keter</b>\n                </a>\n                <b> (Luxembourg, consumer products) </b>\u2013 $100m IPO. Terms TBD (100% prim). <span>GS, JPM, BOFA, JEFF. NYSE \u201cKETR\u201d. BC Partners portfolio company.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001752474&amp;owner=include&amp;count=40\">\n                  <b>KLDiscovery</b>\n                </a>\n                <b> (US, enterprise data analytics) </b>\u2013 $100m uplisting IPO. Terms TBD (100% prim).<span> JPM, BOFA. Exchange/ticker TBD. Trades OTC \u201cKLDI\u201d $6.50 at filing.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001883331&amp;owner=include&amp;count=40\">\n                  <b>Mattress Firm</b>\n                </a>\n                <b> (US, mattress retailer)</b> \u2013 $100m IPO. Terms TBD (100% sec). <span>GS, BARC, JEFF, BARC, UBS, GUGG, PS, TRUIST. NYSE \u201cMFRM\u201d. Controlled by Steinhoff International.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001835615&amp;owner=include&amp;count=40\">\n                  <b>Meihua International Medical Technologies</b>\n                </a>\n                <b> (China, medical devices)</b> \u2013 $55m IPO. 5m shares at $9-$11. <span>PRIME, SHNG</span>.<span> Nasdaq \u201cMHUA\u201d</span>.</p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001874848&amp;owner=include&amp;count=40\">\n                  <b>Milan Laser</b>\n                </a>\n                <b> (US, hair removal retailer) </b>\u2013 $100m IPO. Terms TBD (100% prim).<span> GS, JEFF. NYSE \u201cMLAN\u201d. Green Equity Investors portfolio company.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001854964&amp;owner=include&amp;count=40\">\n                  <b>NewLake Capital Partners</b>\n                </a>\n                <b> (US, cannabis REIT) </b>\u2013 $98m IPO. 3.5m shares (100% prim) at $26-$28. <span>LTMN, COMP. OTCQX \u201c\u201d. Downsized from 4.5m shares on 8/9.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001861520&amp;owner=include&amp;count=40\">\n                  <b>Nuvo</b>\n                </a>\n                <b> (Israel, medical devices/software) </b>\u2013 $50m IPO. Terms TBD (100% prim). <span>CANT, BRBG.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;type=S-1&amp;CIK=0001879848\">\n                  <b>Phoenix Motor</b>\n                </a>\n                <b> (US, EV maker) </b>\u2013 $150m IPO. Terms TBD (100% prim). <span>MAXM, ROTH, EFH. Nasdaq \u201cPEV\u201d</span>.</p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001881487&amp;owner=include&amp;count=40\">\n                  <b>ProFrac</b>\n                </a>\n                <b> (US, oilfield services)</b> \u2013 $100m IPO. Terms TBD (100% prim). <span>JPM, PS, MS. Nasdaq \u201cPFHC.\u201d</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001858721&amp;owner=include&amp;count=40\">\n                  <b>Rotech Healthcare</b>\n                </a>\n                <b> (US, home medical equipment) </b>\u2013 $100m IPO. Terms TBD (100% prim). <span>BOFA, JEFF, UBS, TRST, BARD, RBC. Nasdaq \u201cROTK\u201d. Capital Group, Silver Point and Venor Capital are large existing shareholders.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001891367&amp;owner=include&amp;count=40\">\n                  <b>Rev Renewables</b>\n                </a>\n                <b> (US, renewable energy)</b> \u2013 $100m IPO. Terms TBD (100% prim).<span> MS, GS, RBC, BOFA, CITI, BMO, EVER, WOLF/NOMU. Nasdaq \u201cRVR\u201d. SK E&amp;S investing $100m in concurrent private placement.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001878628&amp;owner=include&amp;count=40\">\n                  <b>Rue Gilt Groupe</b>\n                </a>\n                <b> (US, e-commerce) </b>\u2013 $100m IPO. Terms TBD (100% prim). <span>CITI, BOFA. Nasdaq \u201cRGG\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001400118&amp;owner=include&amp;count=40\">\n                  <b>Sagimet Biosciences</b>\n                </a>\n                <b> (US, biotech) </b>\u2013 $75m IPO. Terms TBD (100% prim). <span>BOFA, COWN, PS. Nasdaq \u201cSGMT\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001542022&amp;owner=include&amp;count=40\">\n                  <b>SambaTV</b>\n                </a>\n                <b> (US, digital media) </b>\u2013 $75m IPO. Terms TBD (100% prim). <span>BOFA, EVER, OPCO. NYSE \u201cSMBA\u201d. </span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001883313&amp;owner=include&amp;count=40\">\n                  <b>Savers Value Village</b>\n                </a>\n                <b> (US, discount retailer)</b> \u2013 $100m IPO. Terms TBD (prim, sec). <span>JPM, GS, JEFF, UBS. NYSE \u201cSVV\u201d. Ares Management is the sponsor. Filed as S-Evergreen Holding.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001884713&amp;owner=include&amp;count=40\">\n                  <b>Specialty Building Products</b>\n                </a>\n                <b> (US, homebuilding materials)</b> \u2013 $100m IPO. Terms TBD (100% prim).<span> BARC, GS, RBC. Nasdaq \u201cSBP\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001872812&amp;owner=include&amp;count=40\">\n                  <b>TC Biopharma</b>\n                </a>\n                <b> (UK, biotech) </b>\u2013 $56.3m IPO. 6.3m shares (100% prim) at $7-$9.<span> EFH. Nasdaq \u201cTCBP\u201d</span>.</p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001860299&amp;owner=include&amp;count=40\">\n                  <b>Thomas James Homes</b>\n                </a>\n                <b> (US, homebuilder) </b>\u2013 $100m IPO. Terms TBD (100% prim). <span>JPM, CITI, BOFA, RBC. Nasdaq \u201cTJH\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/edgar/browse/?CIK=1514587\">\n                  <b>Turo</b>\n                </a>\n                <b> (US, car sharing)</b> \u2013 $100m IPO. Terms TBD (prim, sec). <span>MS, JPM, ALLN, CITI. 5% DSP.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001862979&amp;owner=include&amp;count=40\">\n                  <b>Verdant Earth Technologies</b>\n                </a>\n                <b> (Australia, renewable energy)</b> \u2013 $56.3m IPO. 6.25m shares (100% prim) at $7-$9.<span> ROTH. Nasdaq \u201cVDNT\u201d.</span></p>\n              <p>\n                <b>February: </b>\n                <a href=\"https://www.sec.gov/Archives/edgar/data/1859836/000110465921117942/tm2114709-10_s1.htm\">\n                  <b>Yesway</b>\n                </a>\n                <b> (US, grocery stores) </b>\u2013 $100m IPO. Terms TBD (100% prim). <span>MS, JPM, GS, BMO, BARC. Nasdaq \u201cYSWY\u201d.</span></p>\n              <p>\n                <b>March: </b>\n                <a href=\"https://www.wsj.com/articles/digital-advertising-company-aleph-files-confidentially-for-ipo-11634209200\">\n                  <b>Aleph</b>\n                </a>\n                <b> (Argentina/Cayman Islands, digital advertising) </b>\u2013 $100m IPO. Terms TBD (prim/sec).<span> JPM, CITI, GS, BOFA. NYSE \u201cALEF\u201d.</span></p>\n              <p>\n                <b>March: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001880175&amp;owner=include&amp;count=40\">\n                  <b>Solta Medical</b>\n                </a>\n                <b> (US, medical equipment)</b> \u2013 $100m IPO. Terms TBD (100% sec). <span>GS, MS, CITI, GUGG, BARC, EVER. Nasdaq \u201cSLTA\u201d. Carve-out from Bausch Health.</span></p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://nam12.safelinks.protection.outlook.com/?url=http:%2F%2Fifr-track.refinitiv.com%2Ff%2Fa%2FeHWGPxr2URh8YU0gJ3dDiQ~~%2FAAABiwA~%2FRgRiCapcP0RgaHR0cHM6Ly93d3cuc2VjLmdvdi9jZ2ktYmluL2Jyb3dzZS1lZGdhcj9hY3Rpb249Z2V0Y29tcGFueSZDSUs9MDAwMTc5OTIwNyZvd25lcj1pbmNsdWRlJmNvdW50PTQwVwVzcGNldUIKYCJhJSdgvWciNFIbc3RlcGhlbi5sYWNleUByZWZpbml0aXYuY29tWAQAAAAA&amp;data=04%7C01%7Cstephen.lacey%40refinitiv.com%7C64c7ee00f660475a737608d8cfbb2d45%7C71ad2f6261e244fc9e8586c2827f6de9%7C0%7C0%7C637487750148062056%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=E%2F2KA7ak0%2FPjW8zKrMz2tqp%2FQnreGB326yqkd%2BNajM8%3D&amp;reserved=0\">\n                  <b>Auna</b>\n                </a>\n                <b> (Peru, healthcare)</b> \u2013 $100m IPO. Terms TBD (100% prim). <span>MS. NYSE \u201cAUNA\u201d/BVL \u201cTBA\u201d. Listing in the US and Peru. Filed 9/30/2020.</span></p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001716195&amp;owner=include&amp;count=40\">\n                  <b>Camposol</b>\n                </a>\n                <b> (Peru, fresh produce) </b>\u2013 $450m IPO. Terms TBD (prim, sec). <span>BOFA, UBS, JPM, SCOT, SANT. NYSE \u201cCMSL\u201d, Lima Stock Exchange. Concurrent public offering to Peruvian investors. Filed 4/19/21.</span></p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001801956&amp;owner=include&amp;count=40\">\n                  <b>Claire\u2019s</b>\n                </a>\n                <b> (US, retail) </b>\u2013 $100m IPO. Terms TBD (100% prim). G<span>S, CITI. NYSE \u201cCLRS\u201d. MS removed as JB on 10/27.</span></p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001850030&amp;owner=include&amp;count=40\">\n                  <b>Fresh Market</b>\n                </a>\n                <b> (US, grocery stores) </b>\u2013 $100m IPO. Terms TBD (100% prim). <span>CS, BOFA, BARC, DB, RBC, BMO, GUGG. Nasdaq \u201cTFM\u201d. Apollo portfolio company.</span></p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001835104&amp;owner=include&amp;count=40\">\n                  <b>Intermedia Cloud Communications</b>\n                </a>\n                <b> (US, communication-as-a-service) </b>\u2013 $100m IPO. Terms TBD (100% prim).<span> MS, JPM, CS, EVER, JEFF. Nasdaq \u201cINTM\u201d. NEC Corp investing $40m through concurrent private placement. 5% DSP. Madison Dearborn portfolio company. </span><a href=\"https://www.prnewswire.com/news-releases/intermedia-delays-initial-public-offering-301260126.html\"><span>Postponed on 3/31/21</span></a><span>.</span></p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001506042&amp;owner=include&amp;count=40\">\n                  <b>Navios South American Logistics</b>\n                </a>\n                <b> (Uruguay, shipping)</b> \u2013 $100m IPO. Terms TBD (prim, sec). <span>BOFA, ITAU, UBS, BTGP. Nasdaq/B3 dual listing. Filed 3/2/2021.</span></p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0001841644&amp;owner=include&amp;count=40\">\n                  <b>PicPay</b>\n                </a>\n                <b> (Brazil, fintech) </b>\u2013 $100m IPO. Terms TBD (100% prim). <span>BTG, BRAD, SANT, BARC. Nasdaq \u201cPICS</span>\u201d.</p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://nam12.safelinks.protection.outlook.com/?url=http:%2F%2Fifr-track.refinitiv.com%2Ff%2Fa%2Fb4MHxXQZ7zZCvYDeWhbwKA~~%2FAAABiwA~%2FRgRiCapcP0RgaHR0cHM6Ly93d3cuc2VjLmdvdi9jZ2ktYmluL2Jyb3dzZS1lZGdhcj9hY3Rpb249Z2V0Y29tcGFueSZDSUs9MDAwMTc3MTgxNSZvd25lcj1pbmNsdWRlJmNvdW50PTQwVwVzcGNldUIKYCJhJSdgvWciNFIbc3RlcGhlbi5sYWNleUByZWZpbml0aXYuY29tWAQAAAAA&amp;data=04%7C01%7Cstephen.lacey%40refinitiv.com%7C64c7ee00f660475a737608d8cfbb2d45%7C71ad2f6261e244fc9e8586c2827f6de9%7C0%7C0%7C637487750148101891%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=phyC2RGLflqVWUU%2F%2B6bk7STKIVGnNkd1g62ttsxtSc8%3D&amp;reserved=0\">\n                  <b>PurposeBuilt Brands</b>\n                </a>\n                <b> (US, consumer goods) </b>\u2013 $100m IPO. Terms TBD (100% prim). <span>BARC, MS, GS, BAIRD, BOFA, CS, UBS. Nasdaq \u201cPBLT\u201d. Portfolio company of Carlyle, TA Associates. DSP</span>.</p>\n              <p>\n                <b>2022: </b>\n                <a href=\"http://irdirect.net/prviewer/release_only/id/4819280\">\n                  <b>TypTap Insurance</b>\n                </a>\n                <b> (US, insurtech) </b>\u2013 $100m IPO. Terms TBD (100% prim). <span>JPM, TRST, OPCO. NYSE \u201cTYTP\u201d. </span><a href=\"https://www.globenewswire.com/news-release/2022/01/12/2365988/0/en/HCI-Group-Provides-Update-on-Initial-Public-Offering-of-TypTap-Insurance-Group.html\"><span>Parent HCI put offering on hold 1/12/22</span></a><span>.</span></p>\n              <h3>Confidential IPO filers</h3>\n              <p>\n                <b>2022: Afiniti (US, artificial intelligence) \u2013 </b>\n                <a href=\"https://nam12.safelinks.protection.outlook.com/?url=http:%2F%2Fifr-track.refinitiv.com%2Ff%2Fa%2Fhv1KyhbP1lvBinoQh-dHHg~~%2FAAABiwA~%2FRgRiCapcP4QpAWh0dHA6Ly9pZnItdHJhY2sucmVmaW5pdGl2LmNvbS9mL2EvODFuTjVPLVBVeWpsVjF1QWhycHJPZ35-L0FBQUJpd0F-L1JnUmZjU2hJUDBSamFIUjBjSE02THk5M2QzY3VkR1ZzWldkeVlYQm9MbU52TG5WckwzUmxZMmh1YjJ4dloza3ZNakF4T0M4eE1pOHpNQzloWm1sdWFYUnBMWEJzWVc1ekxUSmliaTFrYVhKbFkzUXRiR2x6ZEdsdVp5MXphR0Z5WlhNdE1qQXhPUzFwY0c4dlZ3VnpjR05sZFVJS0FDTklvNDVkY1dCcldWSWljbTlpWlhKMExuTm9aWEozYjI5a1FIUm9iMjF6YjI1eVpYVjBaWEp6TG1OdmJWZ0VBQUFBQUF-flcFc3BjZXVCCmAiYSUnYL1nIjRSG3N0ZXBoZW4ubGFjZXlAcmVmaW5pdGl2LmNvbVgEAAAAAA~~&amp;data=04%7C01%7Cstephen.lacey%40refinitiv.com%7C64c7ee00f660475a737608d8cfbb2d45%7C71ad2f6261e244fc9e8586c2827f6de9%7C0%7C0%7C637487750148773930%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=A5pERTAq3i%2BXb3%2F5extMQbch32aWdNcab46xikdchio%3D&amp;reserved=0\">\n                  <b>Con</b>\n                </a>\n                <a href=\"https://nam12.safelinks.protection.outlook.com/?url=http:%2F%2Fifr-track.refinitiv.com%2Ff%2Fa%2Fhv1KyhbP1lvBinoQh-dHHg~~%2FAAABiwA~%2FRgRiCapcP4QpAWh0dHA6Ly9pZnItdHJhY2sucmVmaW5pdGl2LmNvbS9mL2EvODFuTjVPLVBVeWpsVjF1QWhycHJPZ35-L0FBQUJpd0F-L1JnUmZjU2hJUDBSamFIUjBjSE02THk5M2QzY3VkR1ZzWldkeVlYQm9MbU52TG5WckwzUmxZMmh1YjJ4dloza3ZNakF4T0M4eE1pOHpNQzloWm1sdWFYUnBMWEJzWVc1ekxUSmliaTFrYVhKbFkzUXRiR2x6ZEdsdVp5MXphR0Z5WlhNdE1qQXhPUzFwY0c4dlZ3VnpjR05sZFVJS0FDTklvNDVkY1dCcldWSWljbTlpWlhKMExuTm9aWEozYjI5a1FIUm9iMjF6YjI1eVpYVjBaWEp6TG1OdmJWZ0VBQUFBQUF-flcFc3BjZXVCCmAiYSUnYL1nIjRSG3N0ZXBoZW4ubGFjZXlAcmVmaW5pdGl2LmNvbVgEAAAAAA~~&amp;data=04%7C01%7Cstephen.lacey%40refinitiv.com%7C64c7ee00f660475a737608d8cfbb2d45%7C71ad2f6261e244fc9e8586c2827f6de9%7C0%7C0%7C637487750148778911%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=nabPhfxS3vHmsyI2DdkKR3BGRmhB9sa2M2e2BdpXwVs%3D&amp;reserved=0\">\n                  <b>sidering direct listing</b>\n                </a>\n                <b>.</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.businesswire.com/news/home/20211119005470/en/Akanda-Corp.-Announces-Confidential-Submission-of-Draft-Registration-Statement-for-Proposed-Initial-Public-Offering\">\n                  <b>Akanda</b>\n                </a>\n                <b> (UK, medical cannabis)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://nam12.safelinks.protection.outlook.com/?url=http:%2F%2Fifr-track.refinitiv.com%2Ff%2Fa%2Fa5o_rM1FzOTNeZsEq1xLXg~~%2FAAABiwA~%2FRgRiCapcP0TxaHR0cDovL2lmci10cmFjay5yZWZpbml0aXYuY29tL2YvYS9KbnJ6YTdjbWJpR1ZaNHo2YkxXbU13fn4vQUFBQml3QX4vUmdSZmNTaElQMFE1YUhSMGNITTZMeTkzZDNjdVluVnphVzVsYzNOM2FYSmxMbU52YlM5dVpYZHpMMmh2YldVdk1qQXhPVEF5TVRrd01EVTFOamd2Wlc0dlZ3VnpjR05sZFVJS0FDTklvNDVkY1dCcldWSWljbTlpWlhKMExuTm9aWEozYjI5a1FIUm9iMjF6YjI1eVpYVjBaWEp6TG1OdmJWZ0VBQUFBQUF-flcFc3BjZXVCCmAiYSUnYL1nIjRSG3N0ZXBoZW4ubGFjZXlAcmVmaW5pdGl2LmNvbVgEAAAAAA~~&amp;data=04%7C01%7Cstephen.lacey%40refinitiv.com%7C64c7ee00f660475a737608d8cfbb2d45%7C71ad2f6261e244fc9e8586c2827f6de9%7C0%7C0%7C637487750148788865%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=uSMBiBeb%2FBcQxhKftCR%2Bqxxqu6xvnfHHP5hLLdEOMlo%3D&amp;reserved=0\">\n                  <b>Axiom Global</b>\n                </a>\n                <b> (US, legal services)</b>\n              </p>\n              <p>\n                <b>2022: Benchling (US, software)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.businesswire.com/news/home/20211221005296/en/Cohesity-Announces-Confidential-Submission-of-Draft-Registration-Statement-for-Proposed-Initial-Public-Offering\">\n                  <b>Cohesity</b>\n                </a>\n                <b> (US, data management software) SoftBank-backed.</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.reuters.com/markets/us/exclusive-softbank-backed-cybereason-confidentially-files-us-ipo-sources-2022-01-31/\">\n                  <b>Cybereason</b>\n                </a>\n                <b> (US, cybersecurity).</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://playcrazygame.com/2021/12/15/ebanx-makes-biggest-acquisition-in-history-as-it-prepares-for-ipo/\">\n                  <b>Ebanx</b>\n                </a>\n                <b> (Brazil, fintech). Advent-backed. Confidentially filed October 2021.</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://finance.yahoo.com/news/ev-dynamics-announces-confidential-submission-233800195.html\">\n                  <b>Ev Dynamics</b>\n                </a>\n                <b> (China/Hong Kong, EVs)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://nam12.safelinks.protection.outlook.com/?url=http:%2F%2Fifr-track.refinitiv.com%2Ff%2Fa%2F8Le-nb8bIlVm5pagFqBZQA~~%2FAAABiwA~%2FRgRiCapcP4RVAWh0dHA6Ly9pZnItdHJhY2sucmVmaW5pdGl2LmNvbS9mL2EvM0lSRXRNN2UwWUZPXzJyRGt1MWJ1UX5-L0FBQUJpd0F-L1JnUmZjU2hJUDBTRWFIUjBjSE02THk5M2QzY3VZblZ6YVc1bGMzTjNhWEpsTG1OdmJTOXVaWGR6TDJodmJXVXZNakF4T0RBek1qZ3dNRFUyTWprdlpXNHZSWFp2YkhabExVSnBiMnh2WjJsamN5MVVhR1Z5WVhCMWNtVXRRbWx2Y0doaGNtMWhKVVV5SlRnd0pUazVjeTFDYVc5c2IyZHBZM010UkdsMmFYTnBiMjR0UVc1dWIzVnVZMlZ6VndWemNHTmxkVUlLQUNOSW80NWRjV0JyV1ZJaWNtOWlaWEowTG5Ob1pYSjNiMjlrUUhSb2IyMXpiMjV5WlhWMFpYSnpMbU52YlZnRUFBQUFBQX5-VwVzcGNldUIKYCJhJSdgvWciNFIbc3RlcGhlbi5sYWNleUByZWZpbml0aXYuY29tWAQAAAAA&amp;data=04%7C01%7Cstephen.lacey%40refinitiv.com%7C64c7ee00f660475a737608d8cfbb2d45%7C71ad2f6261e244fc9e8586c2827f6de9%7C0%7C0%7C637487750148818736%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=RU%2BHc9xpbP8WNk%2BRCqBWd2OwDnVEw0blqfhybxqs1NY%3D&amp;reserved=0\">\n                  <b>Evolve Biologics</b>\n                </a>\n                <b> (Canada, biotech)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.retaildive.com/news/guitar-center-files-confidentially-for-ipo-debtwire/606834/\">\n                  <b>Guitar Center</b>\n                </a>\n                <b> (US, musical instruments retailer)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.prnewswire.com/news-releases/hansa-biopharma-announces-it-has-confidentially-submitted-a-draft-registration-statement-on-form-f-1-to-the-us-sec-relating-to-a-potential-us-ipo-301418268.html\">\n                  <b>Hansa Biopharma</b>\n                </a>\n                <b> (Sweden, biotech)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.prnewswire.com/il/news-releases/iherb-announces-confidential-submission-of-draft-registration-statement-for-proposed-initial-public-offering-808527514.html\">\n                  <b>iHerb</b>\n                </a>\n                <b> (US, consumer health)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.prnewswire.com/news-releases/inmarket-inc-announces-confidential-submission-of-draft-registration-statement-for-proposed-initial-public-listing-301471861.html\">\n                  <b>InMarket</b>\n                </a>\n                <b> (US, marketing software)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.globenewswire.com/news-release/2021/11/29/2342219/0/en/Medigus-Jeffs-Brands-Submitted-Confidential-Draft-Registration-Statement-for-Proposed-U-S-Initial-Public-Offering.html\">\n                  <b>Jeff\u2019s Brands</b>\n                </a>\n                <b> (US, e-commerce)</b>\n              </p>\n              <p>\n                <b>2022: Kymab (US, biotech)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://modpizza.com/press/mod-announces-confidential-submission-of-draft-registration-statement/\">\n                  <b>MOD Pizza</b>\n                </a>\n                <b> (US, restaurant)</b>\n              </p>\n              <p>\n                <b>2022: NewRez (US, mortgages)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.prnewswire.com/news-releases/nextracker-announces-confidential-submission-of-draft-registration-statement-for-proposed-public-listing-301278644.html\">\n                  <b>Nextracker</b>\n                </a>\n                <b> (US, solar trackers)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.nouryon.com/news-and-events/news-overview/2021/nouryon-announces-confidential-submission-of-draft-registration-statement--for-proposed-initial-public-offering/\">\n                  <b>Nouryon</b>\n                </a>\n                <b> (Netherlands, specialty chemicals)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.msn.com/en-us/money/news/education-tech-startup-open-english-files-for-us-ipo/ar-AARZCxZ?ocid=indentnews\">\n                  <b>Open English</b>\n                </a>\n                <b> (US, online language learning)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.sec.gov/Archives/edgar/data/1836894/000134100421000331/form425.htm\">\n                  <b>Panera Brands</b>\n                </a>\n                <b> (US, restaurant)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.reuters.com/markets/stocks/indian-fintech-company-pine-labs-confidentially-files-us-ipo-bloomberg-news-2022-01-10/\">\n                  <b>Pine Labs</b>\n                </a>\n                <b> (India, fintech)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://nam12.safelinks.protection.outlook.com/?url=http:%2F%2Fifr-track.refinitiv.com%2Ff%2Fa%2FA460EEM8dmwO01J_qKCuaQ~~%2FAAABiwA~%2FRgRiCapcP0R-aHR0cHM6Ly9zdG9ja2hvdXNlLmNvbS9uZXdzL3ByZXNzLXJlbGVhc2VzLzIwMjAvMTIvMDIvcHJvZ3Jlc3NpdmUtY2FyZS1hbm5vdW5jZXMtY29uZmlkZW50aWFsLXN1Ym1pc3Npb24tb2YtZHJhZnQtcmVnaXN0cmF0aW9uVwVzcGNldUIKYCJhJSdgvWciNFIbc3RlcGhlbi5sYWNleUByZWZpbml0aXYuY29tWAQAAAAA&amp;data=04%7C01%7Cstephen.lacey%40refinitiv.com%7C64c7ee00f660475a737608d8cfbb2d45%7C71ad2f6261e244fc9e8586c2827f6de9%7C0%7C0%7C637487750148828694%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=0ZBWJIiknJzxXHjiChYTCfErvHyx3hv0fdli0ZgwvnA%3D&amp;reserved=0\">\n                  <b>Progressive Care</b>\n                </a>\n                <b> (US, healthcare)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.globenewswire.com/news-release/2022/01/06/2362451/0/en/Qlik-Announces-Confidential-Submission-of-Draft-Registration-Statement-Related-to-Proposed-Public-Offering.html\">\n                  <b>Qlik</b>\n                </a>\n                <b> (US, data analytics software)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.redditinc.com/blog/reddit-announces-confidential-submission-of-draft-registration-statement-related-to-proposed-public-offering\">\n                  <b>Reddit</b>\n                </a>\n                <b> (US, social media)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://dot.la/servicetitan-ipo-2656478328.html\">\n                  <b>ServiceTitan</b>\n                </a>\n                <b> (US, software)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://ballantynestrong.com/draft-proposed-ipo-strong-global-entertainment-inc/\">\n                  <b>Strong Global Entertainment</b>\n                </a>\n                <b> (US, exhibition screens)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.prnewswire.com/news-releases/sunstream-ivxx-investment-corp-announces-confidential-submission-of-draft-registration-statement-for-proposed-initial-public-offering-301435895.html\">\n                  <b>Sunstream IVXX Investment</b>\n                </a>\n                <b> (US, cannabis-related specialty finance)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://www.prnewswire.com/news-releases/via-announces-confidential-submission-of-draft-registration-statement-related-to-proposed-public-offering-301449178.html?tc=eml_cleartime\">\n                  <b>Via</b>\n                </a>\n                <b> (US, mobility)</b>\n              </p>\n              <p>\n                <b>2022: </b>\n                <a href=\"https://ri.vivaaerobus.com/en\">\n                  <b>Viva Aerobus</b>\n                </a>\n                <b> (Mexico, airline)</b> - <span>Understood to have filed confidentially.</span></p>\n              <h3>Pending M&amp;A Financings</h3>\n              <p>\n                <b>Q1 2022: American Tower (US, cellphone tower) </b>\u2013 $2bn-plus FO/CB. Terms TBD (100% prim). Funding for $10.1bn CoreSite Realty acquisition.</p>\n              <p>\n                <b>Q1 2022: </b>\n                <a href=\"https://investors.swgasholdings.com/static-files/52344a0c-2b42-47f1-b40d-98674cc40793\">\n                  <b>Southwest Gas</b>\n                </a>\n                <b> (US, utility) </b>\u2013 $900m-$1bn FO/CB. Terms TBD (100% prim). Funding for $1.55bn cash purchase of Questar Pipelines from Dominion Energy.</p>\n              <h3>US equities: Jan 1 to Feb 9 2022</h3>\n              <div class=\"story-table-container\"><table class=\"league-table-sdc-c3r story-basic-table\">\n                <thead>\n                  <tr class=\"persist-header\">\n                    <th>\u00a0</th>\n                    <th>Managing bank / group</th>\n                    <th>No of issues</th>\n                    <th>Total US$ (m)</th>\n                    <th>Share (%)</th>\n                  </tr>\n                </thead>\n                <tbody>\n                  <tr>\n                    <td>1</td>\n                    <td>Bank of America</td>\n                    <td>11</td>\n                    <td>1,498.94</td>\n                    <td>17.7</td>\n                  </tr>\n                  <tr>\n                    <td>2</td>\n                    <td>Morgan Stanley</td>\n                    <td>9</td>\n                    <td>1,424.09</td>\n                    <td>16.8</td>\n                  </tr>\n                  <tr>\n                    <td>3</td>\n                    <td>Goldman Sachs</td>\n                    <td>7</td>\n                    <td>1,215.05</td>\n                    <td>14.3</td>\n                  </tr>\n                  <tr>\n                    <td>4</td>\n                    <td>JP Morgan</td>\n                    <td>6</td>\n                    <td>1,107.43</td>\n                    <td>13.1</td>\n                  </tr>\n                  <tr>\n                    <td>5</td>\n                    <td>Citigroup</td>\n                    <td>4</td>\n                    <td>658.41</td>\n                    <td>7.8</td>\n                  </tr>\n                  <tr>\n                    <td>6</td>\n                    <td>RBC</td>\n                    <td>4</td>\n                    <td>515.66</td>\n                    <td>6.1</td>\n                  </tr>\n                  <tr>\n                    <td>7</td>\n                    <td>Jefferies</td>\n                    <td>6</td>\n                    <td>423.45</td>\n                    <td>5.0</td>\n                  </tr>\n                  <tr>\n                    <td>8</td>\n                    <td>Barclays</td>\n                    <td>4</td>\n                    <td>250.25</td>\n                    <td>3.0</td>\n                  </tr>\n                  <tr>\n                    <td>9</td>\n                    <td>Evercore Partners</td>\n                    <td>4</td>\n                    <td>242.88</td>\n                    <td>2.9</td>\n                  </tr>\n                  <tr>\n                    <td>10</td>\n                    <td>SVB Financial Group</td>\n                    <td>3</td>\n                    <td>190.91</td>\n                    <td>2.3</td>\n                  </tr>\n                  <tr>\n                    <td>11</td>\n                    <td>Credit Suisse</td>\n                    <td>1</td>\n                    <td>173.33</td>\n                    <td>2.0</td>\n                  </tr>\n                  <tr>\n                    <td>12</td>\n                    <td>Stifel/KBW</td>\n                    <td>4</td>\n                    <td>156.74</td>\n                    <td>1.8</td>\n                  </tr>\n                  <tr>\n                    <td>13</td>\n                    <td>Wells Fargo</td>\n                    <td>3</td>\n                    <td>127.28</td>\n                    <td>1.5</td>\n                  </tr>\n                  <tr>\n                    <td>14</td>\n                    <td>UBS</td>\n                    <td>2</td>\n                    <td>69.71</td>\n                    <td>0.8</td>\n                  </tr>\n                  <tr>\n                    <td>15</td>\n                    <td>JMP Securities LLC</td>\n                    <td>2</td>\n                    <td>60.14</td>\n                    <td>0.7</td>\n                  </tr>\n                  <tr>\n                    <td>16</td>\n                    <td>Hovde Group LLC</td>\n                    <td>1</td>\n                    <td>55.22</td>\n                    <td>0.7</td>\n                  </tr>\n                  <tr>\n                    <td>17</td>\n                    <td>HSBC</td>\n                    <td>1</td>\n                    <td>37.62</td>\n                    <td>0.4</td>\n                  </tr>\n                  <tr>\n                    <td>18</td>\n                    <td>Truist Financial</td>\n                    <td>1</td>\n                    <td>37.62</td>\n                    <td>0.4</td>\n                  </tr>\n                  <tr>\n                    <td>19</td>\n                    <td>BMO</td>\n                    <td>1</td>\n                    <td>37.62</td>\n                    <td>0.4</td>\n                  </tr>\n                  <tr>\n                    <td>20</td>\n                    <td>William Blair &amp; Co</td>\n                    <td>1</td>\n                    <td>35.58</td>\n                    <td>0.4</td>\n                  </tr>\n                  <tr>\n                    <td>21</td>\n                    <td>Guggenheim Securities</td>\n                    <td>1</td>\n                    <td>24.50</td>\n                    <td>0.3</td>\n                  </tr>\n                  <tr>\n                    <td>22</td>\n                    <td>Maxim Group LLC</td>\n                    <td>2</td>\n                    <td>23.76</td>\n                    <td>0.3</td>\n                  </tr>\n                  <tr>\n                    <td>23</td>\n                    <td>Cowen</td>\n                    <td>1</td>\n                    <td>22.49</td>\n                    <td>0.3</td>\n                  </tr>\n                  <tr>\n                    <td>24</td>\n                    <td>Raymond James Financial Inc</td>\n                    <td>1</td>\n                    <td>21.77</td>\n                    <td>0.3</td>\n                  </tr>\n                  <tr>\n                    <td>25</td>\n                    <td>Aegis Group PLC</td>\n                    <td>1</td>\n                    <td>20.00</td>\n                    <td>0.2</td>\n                  </tr>\n                </tbody>\n                <tfoot>\n                  <tr>\n                    <td>\n                    </td><td>TOTAL</td>\n                    <td>31</td>\n                    <td>8,481.78</td>\n                    <td>100.0</td>\n                  </tr>\n                </tfoot>\n              </table></div>\n              <p>Including all domestic and international deals and rights issues</p>\n              <p>\n                <strong>Source:</strong> Refinitiv <strong>SDC code:</strong> C3r</p>\n              <h3>US convertible bonds: Jan 1 to Feb 9 2022</h3>\n              <div class=\"story-table-container\"><table class=\"league-table-sdc-c9a story-basic-table\">\n                <thead>\n                  <tr class=\"persist-header\">\n                    <th>\u00a0</th>\n                    <th>Managing bank / group</th>\n                    <th>No of issues</th>\n                    <th>Total US$ (m)</th>\n                    <th>Share (%)</th>\n                  </tr>\n                </thead>\n                <tbody>\n                  <tr>\n                    <td>1</td>\n                    <td>JP Morgan</td>\n                    <td>4</td>\n                    <td>1,139.12</td>\n                    <td>33.0</td>\n                  </tr>\n                  <tr>\n                    <td>2</td>\n                    <td>Goldman Sachs</td>\n                    <td>4</td>\n                    <td>792.92</td>\n                    <td>23.0</td>\n                  </tr>\n                  <tr>\n                    <td>3</td>\n                    <td>Morgan Stanley</td>\n                    <td>3</td>\n                    <td>735.42</td>\n                    <td>21.3</td>\n                  </tr>\n                  <tr>\n                    <td>4</td>\n                    <td>Credit Suisse</td>\n                    <td>2</td>\n                    <td>235.42</td>\n                    <td>6.8</td>\n                  </tr>\n                  <tr>\n                    <td>5</td>\n                    <td>Wells Fargo</td>\n                    <td>1</td>\n                    <td>93.75</td>\n                    <td>2.7</td>\n                  </tr>\n                  <tr>\n                    <td>6</td>\n                    <td>Citigroup</td>\n                    <td>1</td>\n                    <td>93.75</td>\n                    <td>2.7</td>\n                  </tr>\n                  <tr>\n                    <td>7</td>\n                    <td>Truist Financial</td>\n                    <td>1</td>\n                    <td>93.75</td>\n                    <td>2.7</td>\n                  </tr>\n                  <tr>\n                    <td>8</td>\n                    <td>BMO</td>\n                    <td>1</td>\n                    <td>93.75</td>\n                    <td>2.7</td>\n                  </tr>\n                  <tr>\n                    <td>9</td>\n                    <td>William Blair &amp; Co</td>\n                    <td>1</td>\n                    <td>57.50</td>\n                    <td>1.7</td>\n                  </tr>\n                  <tr>\n                    <td>10</td>\n                    <td>Bank of America</td>\n                    <td>1</td>\n                    <td>57.50</td>\n                    <td>1.7</td>\n                  </tr>\n                  <tr>\n                    <td>11</td>\n                    <td>RBC</td>\n                    <td>1</td>\n                    <td>57.50</td>\n                    <td>1.7</td>\n                  </tr>\n                </tbody>\n                <tfoot>\n                  <tr>\n                    <td>\n                    </td><td>TOTAL</td>\n                    <td>5</td>\n                    <td>3,450.37</td>\n                    <td>100.0</td>\n                  </tr>\n                </tfoot>\n              </table></div>\n              <p>\n                <strong>Source:</strong> Refinitiv <strong>SDC code:</strong> C9a</p>\n              <p>\n                <strong>The daily\u00a0IFR\u00a0US\u00a0ECM\u00a0Briefing covers US, Canadian and Latin American\u00a0IPOs, as well as secondary and convertible offerings in those markets. For further information or to arrange a trial, <a href=\"mailto:ifr.clientsupport@refinitiv.com\" data-type=\"email\" translate=\"no\">contact client support</a>. </strong>\n              </p>\n              <p>\n                <strong>For feedback, tips, people moves or anything else,</strong>\u00a0<strong>please contact\u00a0</strong><strong><a href=\"mailto:stephen.lacey@refinitiv.com,\" data-type=\"email\" translate=\"no\">stephen.lacey@lseg.com,</a></strong><strong>\u00a0<a href=\"mailto:anthony.hughes@refinitiv.com,\" data-type=\"email\" translate=\"no\">anthony.hughes1@lseg.com</a>\u00a0or\u00a0</strong><strong><a href=\"mailto:robert.sherwood@refinitiv.com\" data-type=\"email\" translate=\"no\">robert.sherwood@lseg.com</a>.</strong></p>\n              <p>(Stephen Lacey)</p>\n              <p>((stephen.lacey@refinitiv.com; 646-337-7349))</p>\n            </span><p class=\"line-break\"><br/></p><p class=\"tr-copyright\">Copyright \u00a9 Refinitiv 2022. Click For Restrictions - https://www.refinitiv.com/en/policies/copyright-notice</p></div>"}